Anatomically shaped stemless shoulder for total shoulder replacement and reverse total shoulder
US-2024050235-A1 · Feb 15, 2024 · US
US9457126B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9457126-B2 |
| Application number | US-201314028136-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 16, 2013 |
| Priority date | Dec 15, 2005 |
| Publication date | Oct 4, 2016 |
| Grant date | Oct 4, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a new composition and medical implant made therefrom, the composition comprising a thick diffusion hardened zone, and preferably further comprising a ceramic layer. The present invention relates to orthopedic implants comprising the new composition, methods of making the new composition, and methods of making orthopedic implants comprising the new composition.
Opening claim text (preview).
What is claimed is: 1. A medical implant comprising: a substrate comprising a biocompatible alloy; a diffusion hardened zone in said substrate, said diffusion hardened zone comprising a diffusion hardening species; a substantially defect free ceramic layer in contact with said diffusion hardened zone, and a metallic hardened layer comprising a surface of said medical implant. 2. The medical implant of claim 1 , having an X-ray diffraction pattern where a reflection of tetragonal phase is negligible. 3. The medical implant of claim 1 , wherein said substrate comprises grain size of less than 10 microns. 4. A medical implant comprising: a substrate comprising a biocompatible alloy; a diffusion hardened zone in said substrate, said diffusion hardened zone comprising a diffusion hardening species; a substantially defect free ceramic layer in contact with said diffusion hardened zone; and a metallic hardened layer comprising a surface of said medical implant; wherein said diffusion hardening species comprises oxygen and said biocompatible alloy comprises zirconium, said medical implant further comprising a ratio of atomic concentration of oxygen to atomic concentration of zirconium that increases in the direction of the substrate. 5. The medical implant of claim 4 , wherein a portion of said increase in the ratio of atomic concentration of oxygen to atomic concentration of zirconium occurs in the metallic hardened layer. 6. The medical implant of claim 4 , wherein said ratio of atomic concentration of oxygen to atomic concentration of zirconium ranges between 0.3 and 1.2. 7. A medical implant comprising: a substrate comprising a biocompatible alloy; a diffusion hardened zone in said substrate, said diffusion hardened zone comprising a diffusion hardening species; a ceramic layer in contact with said diffusion hardened zone; and a metallic hardened layer comprising a surface of said medical implant; wherein the diffusion hardened zone has a layered structure comprising at least two distinct layers under metallographic analysis; and wherein said ceramic layer constitutes a substantially defect free ceramic layer. 8. The medical implant of claim 7 , wherein the diffusion hardening zone comprises a diffusion hardening species concentration that decreases in the direction of the substrate. 9. The medical implant of claim 8 , wherein said concentration is defined by a function selected from the group consisting of an error function, an exponential function, a near uniform distribution function, and any sequential combination thereof. 10. The medical implant of claim 7 , further comprising a monoclinic content of at least 96%. 11. The medical implant of claim 7 , wherein the thickness of said at least two distinct layers are substantially the same. 12. The medical implant of claim 7 , wherein said at least two distinct layers comprise a first layer above a second layer, the thickness of said first layer is greater than said second layer. 13. The medical implant of claim 7 , wherein said substantially defect free ceramic layer comprises a secondary phase extending through substantially the entire thickness of said substantially defect free ceramic layer. 14. The medical implant of claim 7 , wherein said substrate comprises grain size between about 1 micron and about 10 microns.
using elemental oxygen or ozone · CPC title
After-treatment · CPC title
Titanium or titanium-based alloys, e.g. Ti-Ni alloys · CPC title
Oxide-containing component · CPC title
Materials characterised by their function or physical properties · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.